1. Home
  2. CGEM vs NPK Comparison

CGEM vs NPK Comparison

Compare CGEM & NPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEM
  • NPK
  • Stock Information
  • Founded
  • CGEM 2016
  • NPK 1905
  • Country
  • CGEM United States
  • NPK United States
  • Employees
  • CGEM N/A
  • NPK N/A
  • Industry
  • CGEM Biotechnology: Pharmaceutical Preparations
  • NPK Ordnance And Accessories
  • Sector
  • CGEM Health Care
  • NPK Industrials
  • Exchange
  • CGEM Nasdaq
  • NPK Nasdaq
  • Market Cap
  • CGEM 530.0M
  • NPK 615.0M
  • IPO Year
  • CGEM 2021
  • NPK N/A
  • Fundamental
  • Price
  • CGEM $7.67
  • NPK $94.34
  • Analyst Decision
  • CGEM Strong Buy
  • NPK
  • Analyst Count
  • CGEM 5
  • NPK 0
  • Target Price
  • CGEM $30.00
  • NPK N/A
  • AVG Volume (30 Days)
  • CGEM 348.1K
  • NPK 61.0K
  • Earning Date
  • CGEM 08-07-2025
  • NPK 08-05-2025
  • Dividend Yield
  • CGEM N/A
  • NPK 1.05%
  • EPS Growth
  • CGEM N/A
  • NPK 31.39
  • EPS
  • CGEM N/A
  • NPK 5.96
  • Revenue
  • CGEM N/A
  • NPK $415,214,000.00
  • Revenue This Year
  • CGEM N/A
  • NPK N/A
  • Revenue Next Year
  • CGEM N/A
  • NPK N/A
  • P/E Ratio
  • CGEM N/A
  • NPK $15.91
  • Revenue Growth
  • CGEM N/A
  • NPK 23.15
  • 52 Week Low
  • CGEM $6.85
  • NPK $69.58
  • 52 Week High
  • CGEM $21.01
  • NPK $103.93
  • Technical
  • Relative Strength Index (RSI)
  • CGEM 38.41
  • NPK 60.85
  • Support Level
  • CGEM $8.47
  • NPK $91.21
  • Resistance Level
  • CGEM $9.25
  • NPK $100.17
  • Average True Range (ATR)
  • CGEM 0.45
  • NPK 2.61
  • MACD
  • CGEM -0.12
  • NPK 0.24
  • Stochastic Oscillator
  • CGEM 5.06
  • NPK 61.95

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

About NPK National Presto Industries Inc.

National Presto Industries Inc has an eclectic product portfolio consisting of household appliances, ammunition, and diapers. The company operates in three segments namely Defense, Housewares/Small Appliance, and Safety. The defense segment which is engaged in manufacturing 40mm ammunition, precision mechanical and electro-mechanical assemblies, and medium caliber cartridge cases; performs Load, Assemble, and Pack (LAP) operations on ordnance-related products for the U.S. Government and prime contractor. While Housewares/Small Appliance segment designs, markets, and distributes housewares and small electrical appliances; the safety segment provides safety technology empowering organizations and individuals to protect what is more important.

Share on Social Networks: